FDA grants accelerated approval for QALSODY™ (Tofersen)
Biogen Inc. announced April 25 that the U.S. Food and Drug Administration (FDA) has approved…
mnd-admin8. May 2023
Category
Approval
© 2024 MND-NET German Network for Motor Neuron Diseases. Design by K&C Advertising KG